{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:52:20Z","timestamp":1780570340085,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human chronic graft-versus-host disease (CGVHD) shares clinical characteristics with a murine sclerodermatous GVHD (Scl-GVHD, B10.D2\u2009\u2192\u2009BALB\/c) model that is characterized by skin and lung fibrosis. In this study, bone marrow- or adipose tissue-derived human mesenchymal stem cells (hMSCs) were injected into the Scl-GVHD mice to address their therapeutic effect on CGVHD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Lethally irradiated BALB\/c mice were transplanted with B10.D2 T cell-depleted bone marrow with or without spleen cells to generate Scl-GVHD. hMSCs were intravenously treated on days 3, 5, and 7 post-transplantation, and the control antibody or CCL1 blocking antibody was subcutaneously injected according to the same schedule as the hMSCs. Fourteen days after transplantation, the recipient mice were sacrificed, and their skin and lungs were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After the early injection of hMSCs after transplantation, the clinical and pathological severity of Scl-GVHD in the skin was significantly attenuated, whereas the pathological score was exacerbated in the lungs. hMSCs had migrated into the lungs, but not into the skin. CD11b monocyte\/macrophages and CD4 T cells were markedly decreased in skin tissues, whereas there was an early recruitment of CD11b cells, and subsequently increased infiltration of CD4 T cells, in the lungs. Importantly, hMSCs persistently upregulated the expression of CCL1 in the lungs, but not in the skin. Concurrent treatment of hMSCs with a CCL1-blocking antibody alleviated the severity of the lung histopathology score and fibrosis with the preservation of the cutaneous protective effect against CGVHD. Infiltration of CD3 T cells and CD68 macrophages and upregulation of chemokines were also decreased in lung tissues, along with the recruitment of eosinophils and tissue IgE expression. In the skin, chemokine expression was further reduced after CCL1 blockade.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These data demonstrate that despite a protective effect against Scl-GVHD in the skin, administration of hMSCs exacerbated lung fibrosis associated with eosinophilia and airway inflammation through persistent CCL1 upregulation. CCL1 blockade offers a potential treatment of pulmonary complications induced after treatment with hMSCs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-020-01768-7","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T22:02:43Z","timestamp":1593122563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model"],"prefix":"10.1186","volume":"11","author":[{"given":"Ji-Young","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Bin","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeongsin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung Kyu","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"issue":"4","key":"1768_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1182\/blood-2014-08-551994","volume":"125","author":"ME Flowers","year":"2015","unstructured":"Flowers ME, Martin PJ. How we treat chronic graft-versus-host disease. Blood. 2015;125(4):606\u201315.","journal-title":"Blood."},{"issue":"2","key":"1768_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1182\/blood-2002-01-0011","volume":"100","author":"ME Flowers","year":"2002","unstructured":"Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood. 2002;100(2):415\u20139.","journal-title":"Blood."},{"issue":"1","key":"1768_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/leu.2008.276","volume":"23","author":"BS Cho","year":"2009","unstructured":"Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S, et al. Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia. 2009;23(1):78\u201384.","journal-title":"Leukemia."},{"issue":"12","key":"1768_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945\u201356.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"1768_CR5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1001\/archderm.138.7.924","volume":"138","author":"PF Penas","year":"2002","unstructured":"Penas PF, Jones-Caballero M, Aragues M, Fernandez-Herrera J, Fraga J, Garcia-Diez A. Sclerodermatous graft-vs-host disease: clinical and pathological study of 17 patients. Arch Dermatol. 2002;138(7):924\u201334.","journal-title":"Arch Dermatol"},{"issue":"3","key":"1768_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1242\/dmm.006668","volume":"4","author":"MA Schroeder","year":"2011","unstructured":"Schroeder MA, DiPersio JF. Mouse models of graft-versus-host disease: advances and limitations. Dis Model Mech. 2011;4(3):318\u201333.","journal-title":"Dis Model Mech"},{"issue":"1","key":"1768_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1172\/JCI17601","volume":"112","author":"BE Anderson","year":"2003","unstructured":"Anderson BE, McNiff J, Yan J, Doyle H, Mamula M, Shlomchik MJ, et al. Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest. 2003;112(1):101\u20138.","journal-title":"J Clin Invest"},{"issue":"10","key":"1768_CR8","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.163.10.5693","volume":"163","author":"LL McCormick","year":"1999","unstructured":"McCormick LL, Zhang Y, Tootell E, Gilliam AC. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol (Baltimore). 1999;163(10):5693\u20139.","journal-title":"J Immunol (Baltimore)"},{"issue":"6","key":"1768_CR9","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.4049\/jimmunol.168.6.3088","volume":"168","author":"Y Zhang","year":"2002","unstructured":"Zhang Y, McCormick LL, Desai SR, Wu C, Gilliam AC. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol (Baltimore). 2002;168(6):3088\u201398.","journal-title":"J Immunol (Baltimore)"},{"issue":"4","key":"1768_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy."},{"issue":"9","key":"1768_CR11","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.jid.2017.02.986","volume":"137","author":"JY Lim","year":"2017","unstructured":"Lim JY, Ryu DB, Lee SE, Park G, Min CK. Mesenchymal stem cells (MSCs) attenuate cutaneous sclerodermatous graft-versus-host disease (Scl-GVHD) through inhibition of immune cell infiltration in a mouse model. J Invest Dermatol. 2017;137(9):1895\u2013904.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1768_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/icb.2012.56","volume":"91","author":"K English","year":"2013","unstructured":"English K. Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol. 2013;91(1):19\u201326.","journal-title":"Immunol Cell Biol"},{"issue":"7308","key":"1768_CR13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S Mendez-Ferrer","year":"2010","unstructured":"Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466(7308):829\u201334.","journal-title":"Nature."},{"issue":"8","key":"1768_CR14","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/sj.leu.2404777","volume":"21","author":"K Le Blanc","year":"2007","unstructured":"Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, Arvidson J, et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia. 2007;21(8):1733\u20138.","journal-title":"Leukemia."},{"issue":"9624","key":"1768_CR15","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Le Blanc","year":"2008","unstructured":"Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet (London). 2008;371(9624):1579\u201386.","journal-title":"Lancet (London)"},{"issue":"10","key":"1768_CR16","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012;7(10):e47559.","journal-title":"PLoS One"},{"issue":"5","key":"1768_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.bbmt.2005.01.005","volume":"11","author":"K Le Blanc","year":"2005","unstructured":"Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11(5):321\u201334.","journal-title":"Biol Blood Marrow Transplant."},{"issue":"1","key":"1768_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3109\/08820139.2013.843191","volume":"43","author":"JY Lim","year":"2014","unstructured":"Lim JY, Cho BS, Min CK, Park G, Kim YJ, Chung NG, et al. Fluctuations in pathogenic CD4+ T-cell subsets in a murine sclerodermatous model of chronic graft-versus-host disease. Immunol Investig. 2014;43(1):41\u201353.","journal-title":"Immunol Investig"},{"issue":"12","key":"1768_CR19","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.4049\/jimmunol.1100504","volume":"186","author":"MH Oh","year":"2011","unstructured":"Oh MH, Oh SY, Yu J, Myers AC, Leonard WJ, Liu YJ, et al. IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin. J Immunol (Baltimore). 2011;186(12):7232\u201342.","journal-title":"J Immunol (Baltimore)"},{"issue":"3","key":"1768_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jdermsci.2014.02.008","volume":"74","author":"D Le Huu","year":"2014","unstructured":"Le Huu D, Kimura H, Date M, Hamaguchi Y, Hasegawa M, Hau KT, et al. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease. J Dermatol Sci. 2014;74(3):214\u201321.","journal-title":"J Dermatol Sci"},{"issue":"2","key":"1768_CR21","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/ar2991","volume":"12","author":"L Goffin","year":"2010","unstructured":"Goffin L, Seguin-Estevez Q, Alvarez M, Reith W, Chizzolini C. Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts. Arthritis Res Ther. 2010;12(2):R73.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"1768_CR22","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1083\/jcb.137.6.1445","volume":"137","author":"BK Pilcher","year":"1997","unstructured":"Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, Parks WC. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol. 1997;137(6):1445\u201357.","journal-title":"J Cell Biol"},{"issue":"Pt 4","key":"1768_CR23","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1042\/BST0350661","volume":"35","author":"J Gauldie","year":"2007","unstructured":"Gauldie J, Bonniaud P, Sime P, Ask K, Kolb M. TGF-beta, Smad3 and the process of progressive fibrosis. Biochem Soc Trans. 2007;35(Pt 4):661\u20134.","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"1768_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/01902148.2010.524722","volume":"37","author":"E Fagone","year":"2011","unstructured":"Fagone E, Conte E, Gili E, Fruciano M, Pistorio MP, Lo Furno D, et al. Resveratrol inhibits transforming growth factor-beta-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK\/Akt inhibition and PTEN restoration. Exp Lung Res. 2011;37(3):162\u201374.","journal-title":"Exp Lung Res"},{"issue":"12","key":"1768_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/sj.bmt.1703563","volume":"29","author":"JY New","year":"2002","unstructured":"New JY, Li B, Koh WP, Ng HK, Tan SY, Yap EH, et al. T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease. Bone Marrow Transplant. 2002;29(12):979\u201386.","journal-title":"Bone Marrow Transplant"},{"key":"1768_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fphar.2012.00023","volume":"3","author":"MG Castor","year":"2012","unstructured":"Castor MG, Pinho V, Teixeira MM. The role of chemokines in mediating graft versus host disease: opportunities for novel therapeutics. Front Pharmacol. 2012;3:23.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1768_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1471-4892(03)00069-9","volume":"3","author":"CM Lloyd","year":"2003","unstructured":"Lloyd CM, Rankin SM. Chemokines in allergic airway disease. Curr Opin Pharmacol. 2003;3(4):443\u20138.","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"1768_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12931-018-0813-0","volume":"19","author":"A Matucci","year":"2018","unstructured":"Matucci A, Vultaggio A, Maggi E, Kasujee I. Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question? Respir Res. 2018;19(1):113.","journal-title":"Respir Res"},{"issue":"6","key":"1768_CR29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3727\/096368910X508762","volume":"19","author":"H Yagi","year":"2010","unstructured":"Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, et al. Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant. 2010;19(6):667\u201379.","journal-title":"Cell Transplant"},{"issue":"5","key":"1768_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/xen.12000","volume":"19","author":"J Li","year":"2012","unstructured":"Li J, Ezzelarab MB, Cooper DK. Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation. Xenotransplantation. 2012;19(5):273\u201385.","journal-title":"Xenotransplantation"},{"issue":"12","key":"1768_CR31","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3727\/096368909X474230","volume":"18","author":"O Detante","year":"2009","unstructured":"Detante O, Moisan A, Dimastromatteo J, Richard MJ, Riou L, Grillon E, et al. Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution. Cell Transplant. 2009;18(12):1369\u201379.","journal-title":"Cell Transplant"},{"issue":"7","key":"1768_CR32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.nucmedbio.2011.03.008","volume":"38","author":"A Gholamrezanezhad","year":"2011","unstructured":"Gholamrezanezhad A, Mirpour S, Bagheri M, Mohamadnejad M, Alimoghaddam K, Abdolahzadeh L, et al. In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol. 2011;38(7):961\u20137.","journal-title":"Nucl Med Biol"},{"issue":"21","key":"1768_CR33","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1089\/scd.2013.0193","volume":"22","author":"MJ Hoogduijn","year":"2013","unstructured":"Hoogduijn MJ, Roemeling-van Rhijn M, Engela AU, Korevaar SS, Mensah FK, Franquesa M, et al. Mesenchymal stem cells induce an inflammatory response after intravenous infusion. Stem Cells Dev. 2013;22(21):2825\u201335.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"1768_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0008-8749(83)90001-1","volume":"77","author":"BD Jaffee","year":"1983","unstructured":"Jaffee BD, Claman HN. Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems. Cell Immunol. 1983;77(1):1\u201312.","journal-title":"Cell Immunol"},{"issue":"1","key":"1768_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1346-8138.2009.00764.x","volume":"37","author":"T Yamamoto","year":"2010","unstructured":"Yamamoto T. Animal model of systemic sclerosis. J Dermatol. 2010;37(1):26\u201341.","journal-title":"J Dermatol"},{"key":"1768_CR36","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","volume":"32","author":"JW Griffith","year":"2014","unstructured":"Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 2014;32:659\u2013702.","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"1768_CR37","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/ni.f.212","volume":"9","author":"P Friedl","year":"2008","unstructured":"Friedl P, Weigelin B. Interstitial leukocyte migration and immune function. Nat Immunol. 2008;9(9):960\u20139.","journal-title":"Nat Immunol"},{"issue":"7","key":"1768_CR38","doi-asserted-by":"publisher","first-page":"L603","DOI":"10.1152\/ajplung.00203.2014","volume":"308","author":"T Tomankova","year":"2015","unstructured":"Tomankova T, Kriegova E, Liu M. Chemokine receptors and their therapeutic opportunities in diseased lung: far beyond leukocyte trafficking. Am J Physiol Lung Cell Mol Physiol. 2015;308(7):L603\u201318.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"1768_CR39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4049\/jimmunol.163.1.403","volume":"163","author":"JA Gonzalo","year":"1999","unstructured":"Gonzalo JA, Pan Y, Lloyd CM, Jia GQ, Yu G, Dussault B, et al. Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J Immunol (Baltimore). 1999;163(1):403\u201311.","journal-title":"J Immunol (Baltimore)"},{"issue":"3","key":"1768_CR40","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.4049\/jimmunol.166.3.2055","volume":"166","author":"S Kawasaki","year":"2001","unstructured":"Kawasaki S, Takizawa H, Yoneyama H, Nakayama T, Fujisawa R, Izumizaki M, et al. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. Journal of immunology (Baltimore). 2001;166(3):2055\u201362.","journal-title":"Journal of immunology (Baltimore)"},{"issue":"9","key":"1768_CR41","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.4049\/jimmunol.170.9.4810","volume":"170","author":"B Bishop","year":"2003","unstructured":"Bishop B, Lloyd CM. CC chemokine ligand 1 promotes recruitment of eosinophils but not Th2 cells during the development of allergic airways disease. J Immunol (Baltimore). 2003;170(9):4810\u20137.","journal-title":"J Immunol (Baltimore)"},{"issue":"8","key":"1768_CR42","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.4049\/jimmunol.164.8.4048","volume":"164","author":"M Inngjerdingen","year":"2000","unstructured":"Inngjerdingen M, Damaj B, Maghazachi AA. Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J Immunol (Baltimore). 2000;164(8):4048\u201354.","journal-title":"J Immunol (Baltimore)"},{"issue":"4","key":"1768_CR43","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4049\/jimmunol.174.4.1962","volume":"174","author":"CM Freeman","year":"2005","unstructured":"Freeman CM, Chiu BC, Stolberg VR, Hu J, Zeibecoglou K, Lukacs NW, et al. CCR8 is expressed by antigen-elicited, IL-10-producing CD4+CD25+ T cells, which regulate Th2-mediated granuloma formation in mice. J Immunol (Baltimore). 2005;174(4):1962\u201370.","journal-title":"J Immunol (Baltimore)"},{"issue":"2","key":"1768_CR44","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/blood.V97.2.367","volume":"97","author":"M Inngjerdingen","year":"2001","unstructured":"Inngjerdingen M, Damaj B, Maghazachi AA. Expression and regulation of chemokine receptors in human natural killer cells. Blood. 2001;97(2):367\u201375.","journal-title":"Blood."},{"issue":"10","key":"1768_CR45","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.4049\/jimmunol.177.10.6940","volume":"177","author":"D Soler","year":"2006","unstructured":"Soler D, Chapman TR, Poisson LR, Wang L, Cote-Sierra J, Ryan M, et al. CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes. J Immunol (Baltimore). 2006;177(10):6940\u201351.","journal-title":"J Immunol (Baltimore)"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01768-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-020-01768-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01768-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T08:58:17Z","timestamp":1723107497000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01768-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1768"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01768-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-19594\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-19594\/v2","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"26 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Animal Care and Use Committee (IACUC) and the Department of Laboratory Animals (DOLA) at the Catholic University of Korea, Songeui Campus, accredited the Korea Excellence Animal laboratory Facility from the Korea Food and Drug Administration in 2017 and acquired AAALAC International full accreditation in 2018. All procedures involving animals were in accordance with the Laboratory Animals Welfare Act, the Guide for the Care and Use of Laboratory Animals, and the Guidelines and Policies for Rodent Experimentation provided by the Institutional Animal Care and Use Committee of the School of Medicine of the Catholic University of Korea. The study protocol was approved by the Institutional Review Board of the Catholic University of Korea (CUMC-2016-0062-03).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"254"}}